Terms: = Testicular cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272
5 results:
1. Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays.
Skotheim RI; Abeler VM; Nesland JM; Fosså SD; Holm R; Wagner U; Flørenes VA; Aass N; Kallioniemi OP; Lothe RA
Neoplasia; 2003; 5(5):397-404. PubMed ID: 14670177
[TBL] [Abstract] [Full Text] [Related]
2. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract] [Full Text] [Related]
3. Loss of fhit expression in testicular germ cell tumors and intratubular germ cell neoplasia.
Eyzaguirre E; Gatalica Z
Mod Pathol; 2002 Oct; 15(10):1068-72. PubMed ID: 12379753
[TBL] [Abstract] [Full Text] [Related]
4. Alterations of the fragile histidine triad gene, fhit, and its encoded products contribute to testicular germ cell tumorigenesis.
Kraggerud SM; Aman P; Holm R; Stenwig AE; Fosså SD; Nesland JM; Lothe RA
Cancer Res; 2002 Jan; 62(2):512-7. PubMed ID: 11809703
[TBL] [Abstract] [Full Text] [Related]
5. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?
Oliver RT; Edmonds PM; Ong JY; Ostrowski MJ; Jackson AW; Baille-Johnson H; Williams MV; Wiltshire CR; Mott T; Pratt WR
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):3-8. PubMed ID: 8175442
[TBL] [Abstract] [Full Text] [Related]
